Follow
Christopher Lo
Christopher Lo
Broad Institute of MIT and Harvard
Verified email at broadinstitute.org
Title
Cited by
Cited by
Year
Next-generation characterization of the cancer cell line encyclopedia
M Ghandi, FW Huang, J Jané-Valbuena, GV Kryukov, CC Lo, ...
Nature 569 (7757), 503-508, 2019
22532019
Sensitive detection of minimal residual disease in patients treated for early-stage breast cancer
HA Parsons, J Rhoades, SC Reed, G Gydush, P Ram, P Exman, K Xiong, ...
Clinical Cancer Research 26 (11), 2556-2564, 2020
1272020
Tumor fraction in cell-free DNA as a biomarker in prostate cancer
AD Choudhury, L Werner, E Francini, XX Wei, G Ha, SS Freeman, ...
JCI insight 3 (21), 2018
1082018
Targetable vulnerabilities in T-and NK-cell lymphomas identified through preclinical models
SY Ng, N Yoshida, AL Christie, M Ghandi, NV Dharia, J Dempster, ...
Nature communications 9 (1), 2024, 2018
922018
Learning structured predictors from bandit feedback for interactive NLP
A Sokolov, J Kreutzer, C Lo, S Riezler
Proceedings of the 54th Annual Meeting of the Association for Computational …, 2016
372016
Liquid biopsy detection of genomic alterations in pediatric brain tumors from cell-free DNA in peripheral blood, CSF, and urine
M Pagès, D Rotem, G Gydush, S Reed, J Rhoades, G Ha, C Lo, ...
Neuro-oncology 24 (8), 1352-1363, 2022
332022
Stochastic structured prediction under bandit feedback
A Sokolov, J Kreutzer, S Riezler, C Lo
Advances in neural information processing systems 29, 2016
332016
Tumor fraction in circulating free DNA as a biomarker of disease dynamics in metastatic prostate cancer.
AD Choudhury, L Werner, G Ha, S Freeman, J Rhoades, S Reed, ...
Journal of Clinical Oncology 36 (6_suppl), 195-195, 2018
22018
909: Methylation profile of circulating cfDNA at term demonstrates relatively low placental contribution to hypomethylated cfDNA
M Mhatre, C Clifford, C Lo, K Xiong, V Adalsteinsson, V Iyer, A Taymoori, ...
American Journal of Obstetrics & Gynecology 220 (1), S587-S588, 2019
12019
broad/IBM project: discovery of treatment resistance mechanisms through use of liquid biopsy genomics services
G Getz, C Cibulskis, I Leshchiner, M Hanna, D Livitz, K Slowik, C Levovitz, ...
Cancer Research 78 (13_Supplement), 3001-3001, 2018
12018
FinaleMe: Predicting DNA methylation by the fragmentation patterns of plasma cell-free DNA
Y Liu, SC Reed, C Lo, AD Choudhury, HA Parsons, DG Stover, G Ha, ...
bioRxiv, 2024.01. 02.573710, 2024
2024
Genotyping calling from expression data in recount3
CC Lo
Johns Hopkins University, 2023
2023
Genotype prediction of 336,463 samples from public expression data
A Razi, CC Lo, S Wang, JT Leek, KD Hansen
bioRxiv, 2023.10. 21.562237, 2023
2023
Abstract P5-01-03: Ultrasensitive detection of minimal residual disease in patients treated for breast cancer
HA Parsons, J Rhoades, SC Reed, G Gydush, P Ram, P Exman, K Xiong, ...
Cancer Research 80 (4_Supplement), P5-01-03-P5-01-03, 2020
2020
587: The methylation profile of circulating cfDNA is affected by maternal obesity and labor
M Mhatre, C Clifford, C Lo, K Xiong, V Adalsteinsson, V Iyer, A Taymoori, ...
American Journal of Obstetrics & Gynecology 220 (1), S390, 2019
2019
Abstract LB-225: Liquid biopsies identify trunk mutations and reflect multiple tumors in a patient
SS Freeman, Z Lin, G Ha, I Leshchiner, J Rhoades, D Livitz, D Rosebrock, ...
Cancer Research 78 (13_Supplement), LB-225-LB-225, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–16